eBook – iPSCs: from the bench to the clinic

Written by Bio-Techne
Basic research Cell therapy Clinical trials iPSCs Manufacturing & scale-up

In this eBook, we explore the quality control guidelines for clinical-grade human iPSC lines and delve further into raw/ancillary material qualification for stem cell therapy manufacturing. We also take a look at the therapeutic potential of these cells, including the first trial of iPSCs for Parkinson’s disease.

Contents include:

  • [FOREWORD] Welcome to our eBook on iPSCs: from the bench to the clinic
  • [INTERVIEW] Continuous innovation for manufacturing raw/ancillary materials at scale: an interview with Sean Kevlahan
  • [OPINION ARTICLE] Raw/ancillary material qualification for stem cell therapy manufacturing
  • [WHITE PAPER] Quality control guidelines for clinical-grade human induced pluripotent stem cell lines
  • [INTERVIEW] Preparing for the first human trial of induced pluripotent stem cell-derived cells for Parkinson’s disease: an interview with Jun Takahashi
  • [INTERVIEW] The therapeutic potential of iPSCs: an interview with Ross Macdonald

To gain access and download this FREE eBook complete the short form below:



In association with: